Survival analysis revealed that high CH25H expression was correlated with poor prognosis in patients with GC (OS, p = 0.0032, left) and EGC (TNM‐I, OS, p = 0.044, right) (Figure 3H). The gene discussed is CH25H; the disease is gastric cancer.